cycloheximide has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Einhorn, S; Erickson, S; Grandér, D; Gruber, A; Pisa, P; Sangfelt, O; Szeps, M; Xu, D | 1 |
1 other study(ies) available for cycloheximide and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
Topics: Acute Disease; Antineoplastic Agents; Burkitt Lymphoma; Cell Cycle; Cycloheximide; Depression, Chemical; DNA Replication; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Induction; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Protein Synthesis Inhibitors; Recombinant Proteins; RNA; RNA, Messenger; RNA, Neoplasm; T-Lymphocytes; Telomerase; Transcription, Genetic; Tumor Cells, Cultured | 2000 |